Clinical Study Results

Did any adverse reactions happen during this study?
There were 15.0% of participants who had adverse reactions during the study that the study doctors thought might be related to savolitinib. This was 3 out of 20 participants.
There were 50.0% of participants who had adverse reactions during the study that the study doctors thought might be related to rifampicin. This was 9 out of 18 participants.
The table below shows how many participants had adverse reactions.

Adverse reactions during this study
Savolitinib Rifampicin
15.0% (3) 50.0% (9)

How many participants had adverse reactions?
15.0% (3) 50.0% (9)

How many participants left this study due to adverse reactions?
5.0% (1) 0.0% (0)

7